These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 25218680)

  • 1. Brain atrophy in peritoneal dialysis and CKD stages 3-5: a cross-sectional and longitudinal study.
    Tsuruya K; Yoshida H; Kuroki Y; Nagata M; Mizumasa T; Mitsuiki K; Yoshiura T; Hirakawa M; Kanai H; Hori K; Hirakata H; Kitazono T
    Am J Kidney Dis; 2015 Feb; 65(2):312-21. PubMed ID: 25218680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Significance of Fronto-Temporal Gray Matter Atrophy in Executive Dysfunction in Patients with Chronic Kidney Disease: The VCOHP Study.
    Tsuruya K; Yoshida H; Haruyama N; Fujisaki K; Hirakata H; Kitazono T
    PLoS One; 2015; 10(12):e0143706. PubMed ID: 26632813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More rapid progression of brain atrophy in patients on peritoneal dialysis compared with hemodialysis: The VCOHP Study.
    Tsuruya K; Yoshida H; Yamada S; Haruyama N; Tanaka S; Tsuchimoto A; Eriguchi M; Fujisaki K; Torisu K; Nakano T; Masutani K; Kitazono T
    Hypertens Res; 2024 Apr; 47(4):887-897. PubMed ID: 38123712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of CKD and dialysis modality on exposure to drugs cleared by nonrenal mechanisms.
    Thomson BK; Nolin TD; Velenosi TJ; Feere DA; Knauer MJ; Asher LJ; House AA; Urquhart BL
    Am J Kidney Dis; 2015 Apr; 65(4):574-82. PubMed ID: 25453994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gray matter atrophy and disability progression in patients with early relapsing-remitting multiple sclerosis: a 5-year longitudinal study.
    Horakova D; Dwyer MG; Havrdova E; Cox JL; Dolezal O; Bergsland N; Rimes B; Seidl Z; Vaneckova M; Zivadinov R
    J Neurol Sci; 2009 Jul; 282(1-2):112-9. PubMed ID: 19168190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Illness perceptions and treatment perceptions of patients with chronic kidney disease: different phases, different perceptions?
    Jansen DL; Heijmans MJ; Rijken M; Spreeuwenberg P; Grootendorst DC; Dekker FW; Boeschoten EW; Kaptein AA; Groenewegen PP
    Br J Health Psychol; 2013 May; 18(2):244-62. PubMed ID: 23126527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normative estimates of cross-sectional and longitudinal brain volume decline in aging and AD.
    Fotenos AF; Snyder AZ; Girton LE; Morris JC; Buckner RL
    Neurology; 2005 Mar; 64(6):1032-9. PubMed ID: 15781822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of stroke in long-term dialysis patients compared with the general population.
    Wang HH; Hung SY; Sung JM; Hung KY; Wang JD
    Am J Kidney Dis; 2014 Apr; 63(4):604-11. PubMed ID: 24290244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and diffusional brain abnormality related to relatively low level alcohol consumption.
    Sasaki H; Abe O; Yamasue H; Fukuda R; Yamada H; Takei K; Suga M; Takao H; Kasai K; Aoki S; Ohtomo K
    Neuroimage; 2009 Jun; 46(2):505-10. PubMed ID: 19233298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrovascular effects of hemodialysis in chronic kidney disease.
    Prohovnik I; Post J; Uribarri J; Lee H; Sandu O; Langhoff E
    J Cereb Blood Flow Metab; 2007 Nov; 27(11):1861-9. PubMed ID: 17406658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malnutrition-inflammation is a risk factor for cerebral small vessel diseases and cognitive decline in peritoneal dialysis patients: a cross-sectional observational study.
    Zheng K; Wang H; Hou B; You H; Yuan J; Luo K; Chen L; Li M; Xu Q; Zhu Y; Cui L; Nigwekar SU; Feng F; Li X
    BMC Nephrol; 2017 Dec; 18(1):366. PubMed ID: 29262796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of leukoaraiosis in cerebral magnetic resonance images of patients on peritoneal dialysis.
    Kim CD; Lee HJ; Kim DJ; Kim BS; Shin SK; Do JY; Jang MH; Park SH; Kim YS; Kim YL
    Am J Kidney Dis; 2007 Jul; 50(1):98-107. PubMed ID: 17591529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional cerebral gray matter atrophy is associated with cognitive impairment in hemodialysis patients: a cross-sectional and longitudinal voxel-based morphological MRI study.
    Wang H; Huang L; Wu G; Li J; Liu L; Zhang T; Zhu J; Zhang X; Shen W; Chai C; Xia S
    Brain Imaging Behav; 2022 Jun; 16(3):1284-1293. PubMed ID: 34993881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary and lifestyle factors in multiple sclerosis progression: results from a 5-year longitudinal MRI study.
    Jakimovski D; Weinstock-Guttman B; Gandhi S; Guan Y; Hagemeier J; Ramasamy DP; Fuchs TA; Browne RW; Bergsland N; Dwyer MG; Ramanathan M; Zivadinov R
    J Neurol; 2019 Apr; 266(4):866-875. PubMed ID: 30758665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentrations of immunoglobulin free light chains in cerebrospinal fluid predict increased level of brain atrophy in multiple sclerosis.
    Nazarov V; Makshakov G; Kalinin I; Lapin S; Surkova E; Mikhailova L; Gilburd B; Skoromets A; Evdoshenko E
    Immunol Res; 2018 Dec; 66(6):761-767. PubMed ID: 30635824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Reduction of gray and white matters in patients with temporal lobe epilepsy and its correlation with disease duration].
    Lu JJ; Li WJ; He HG; Feng F; Jin ZY; Wu LW
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Jun; 35(3):286-93. PubMed ID: 23827066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain volume alteration and the correlations with the clinical characteristics in drug-naïve first-episode MDD patients: a voxel-based morphometry study.
    Cheng YQ; Xu J; Chai P; Li HJ; Luo CR; Yang T; Li L; Shan BC; Xu XF; Xu L
    Neurosci Lett; 2010 Aug; 480(1):30-4. PubMed ID: 20594947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic kidney disease epidemiology collaboration equation accuracy in predicting peritoneal dialysis-delivered creatinine clearance.
    Filiopoulos V; Koutis I; Takouli L; Arvanitis D; Panagiotopoulos K; Vlassopoulos D
    Ren Fail; 2013; 35(1):88-93. PubMed ID: 23151212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The atrophy of white and gray matter volume in patients with comitant strabismus: Evidence from a voxel-based morphometry study.
    Ouyang J; Yang L; Huang X; Zhong YL; Hu PH; Zhang Y; Pei CG; Shao Y
    Mol Med Rep; 2017 Sep; 16(3):3276-3282. PubMed ID: 28713925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain volumetry in Parkinson's disease with and without dementia: where are the differences?
    Lee SH; Kim SS; Tae WS; Lee SY; Lee KU; Jhoo J
    Acta Radiol; 2013 Jun; 54(5):581-6. PubMed ID: 23474765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.